Bibliographic Details
Title: |
Evaluation of efficacy and safety of rituximab in patients with progressive interstitial lung disease (ILD) with inflammatory component (EvER-ILD2): A multicentre double-blind placebo-controlled randomized trial |
Authors: |
Ferreira, Marion, Bejan-Angoulvant, Theodora, Marchand-Adam, Sylvain, Mousset, Elodie, Mureau, Elody, Jouneau, Stéphane, Nunes, Hilario, Montani, David, Chenivesse, Cécile, Cadranel, Jacques, Bonniaud, Philippe, Crestani, Bruno, Cottin, Vincent, Caille, Agnès |
Source: |
In Respiratory Medicine and Research May 2025 87 |
Database: |
ScienceDirect |